138 related articles for article (PubMed ID: 34663530)
1. Oncologic safety of minimally invasive surgery in non-endometrioid endometrial cancer.
Ahn JH; Park DC; Yoon JH; Lee SJ; Cha J; Yoo JG; Lee HN; Kim SI
Asian J Surg; 2022 Jun; 45(6):1253-1258. PubMed ID: 34663530
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Minimally Invasive and Open Surgery for the Treatment of Endometrial Cancer with a High Risk of Recurrence: A Propensity Score Matching Study in Korea and Taiwan.
Chang CS; Lai YL; Choi CH; Kim TJ; Lee JW; Kim BG; Cheng WF; Chen YL; Lee YY
Ann Surg Oncol; 2023 Oct; 30(11):6855-6864. PubMed ID: 37386310
[TBL] [Abstract][Full Text] [Related]
3. Survival rates of patients who undergo minimally invasive surgery for endometrial cancer with cervical involvement.
Kim SI; Park DC; Lee SJ; Song MJ; Kim CJ; Lee HN; Yoon JH
Int J Med Sci; 2021; 18(10):2204-2208. PubMed ID: 33859528
[No Abstract] [Full Text] [Related]
4. Use and outcomes of minimally invasive hysterectomy for women with nonendometrioid endometrial cancers.
Nieto VL; Huang Y; Hou JY; Tergas AI; St Clair CM; Ananth CV; Neugut AI; Hershman DL; Wright JD
Am J Obstet Gynecol; 2018 Nov; 219(5):463.e1-463.e12. PubMed ID: 30086293
[TBL] [Abstract][Full Text] [Related]
5. Minimally Invasive Compared With Open Hysterectomy in High-Risk Endometrial Cancer.
Segarra-Vidal B; Dinoi G; Zorrilla-Vaca A; Mariani A; Student V; Garcia NA; Llueca Abella A; Ramirez PT
Obstet Gynecol; 2021 Dec; 138(6):828-837. PubMed ID: 34735382
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of minimally invasive surgery for patients with endometrial carcinoma involving the cervix.
Nasioudis D; Frey MK; Chapman-Davis E; Caputo TA; Holcomb K
Int J Gynecol Cancer; 2020 May; 30(5):619-625. PubMed ID: 32276935
[TBL] [Abstract][Full Text] [Related]
7. Minimally invasive surgery for patients with advanced stage endometrial cancer.
Kim SI; Park DC; Lee SJ; Yoo JG; Song MJ; Kim CJ; Lee HN; Yoon JH
Int J Med Sci; 2021; 18(5):1153-1158. PubMed ID: 33526975
[No Abstract] [Full Text] [Related]
8. Impact of surgical approach on prevalence of positive peritoneal cytology and lymph-vascular invasion in patients with early-stage endometrial carcinoma: a National Cancer Database study.
Nasioudis D; Ko EM; Cory L; Latif N
Int J Gynecol Cancer; 2021 Jul; 31(7):1001-1006. PubMed ID: 33853880
[TBL] [Abstract][Full Text] [Related]
9. Minimally Invasive Approach in Type II Endometrial Cancer: Is It Wise and Safe?
Monterossi G; Ghezzi F; Vizza E; Zannoni GF; Uccella S; Corrado G; Restaino S; Quagliozzi L; Casarin J; Dinoi G; Scambia G; Fanfani F
J Minim Invasive Gynecol; 2017; 24(3):438-445. PubMed ID: 28065812
[TBL] [Abstract][Full Text] [Related]
10. Impact of uterine manipulator on oncological outcome in endometrial cancer surgery.
Padilla-Iserte P; Lago V; Tauste C; Díaz-Feijoo B; Gil-Moreno A; Oliver R; Coronado P; Martín-Salamanca MB; Pantoja-Garrido M; Marcos-Sanmartin J; Gilabert-Estellés J; Lorenzo C; Cazorla E; Roldán-Rivas F; Rodríguez-Hernández JR; Sánchez L; Muruzábal JC; Hervas D; Domingo S;
Am J Obstet Gynecol; 2021 Jan; 224(1):65.e1-65.e11. PubMed ID: 32693096
[TBL] [Abstract][Full Text] [Related]
11. Comparison of minimally invasive versus open surgery in the treatment of endometrial carcinosarcoma.
Pedra Nobre S; Mueller JJ; Gardner GJ; Long Roche K; Brown CL; Soslow RA; Alektiar KM; Sonoda Y; Broach VA; Jewell EL; Zivanovic O; Chi DS; Abu-Rustum NR; Leitao MM
Int J Gynecol Cancer; 2020 Aug; 30(8):1162-1168. PubMed ID: 32690592
[TBL] [Abstract][Full Text] [Related]
12. Survival of microsatellite-stable endometrioid endometrial cancer patients after minimally invasive surgery: An analysis of the Cancer Genome Atlas data.
Dai Y; Wang Z; Wang J
Gynecol Oncol; 2020 Jul; 158(1):92-98. PubMed ID: 32376044
[TBL] [Abstract][Full Text] [Related]
13. Vulvar metastasis of an early-stage well-differentiated endometrial cancer after minimally invasive surgery.
Abdullah A; Seagle BL; Bautista E; Hansra BS; Samuelson R; Shahabi S
J Minim Invasive Gynecol; 2014; 21(4):708-11. PubMed ID: 24509288
[TBL] [Abstract][Full Text] [Related]
14. Surgical and oncologic outcomes of minimally invasive surgery for stage I high-grade endometrial cancer.
Nasioudis D; Heyward QD; Haggerty AF; Giuntoli Ii RL; Burger RA; Morgan MA; Ko EM; Latif NA
Surg Oncol; 2020 Sep; 34():7-12. PubMed ID: 32103792
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of survival outcomes between minimally invasive and open surgery in the treatment of early-stage endometrial cancer: a population-based study in Osaka Japan.
Sasano T; Mabuchi S; Komura N; Maeda M; Kamiura S; Morishima T; Miyashiro I
Jpn J Clin Oncol; 2023 Aug; 53(9):791-797. PubMed ID: 37366149
[TBL] [Abstract][Full Text] [Related]
16. Long-term oncological safety of minimally invasive surgery in high-risk endometrial cancer.
Koskas M; Jozwiak M; Fournier M; Vergote I; Trum H; Lok C; Amant F
Eur J Cancer; 2016 Sep; 65():185-91. PubMed ID: 27505629
[TBL] [Abstract][Full Text] [Related]
17. Minimally invasive surgery versus laparotomy in women with high grade endometrial cancer: a multi-site study performed at high volume cancer centers.
Fader AN; Seamon LG; Escobar PF; Frasure HE; Havrilesky LA; Zanotti KM; Secord AA; Boggess JF; Cohn DE; Fowler JM; Skafianos G; Rossi E; Gehrig PA
Gynecol Oncol; 2012 Aug; 126(2):180-5. PubMed ID: 22555102
[TBL] [Abstract][Full Text] [Related]
18. Minimally invasive surgery does not impair overall survival in stage IIIC endometrial cancer patients.
Papadia A; Garbade A; Gasparri ML; Wang J; Radan AP; Mueller MD
Arch Gynecol Obstet; 2020 Feb; 301(2):585-590. PubMed ID: 31781888
[TBL] [Abstract][Full Text] [Related]
19. Recurrence and Survival Rates of Patients Who Undergo Minimally Invasive Surgery for Endometrial Carcinoma with Different Prognostic Risk Groups.
Liu B; Lin J; Liu W; Chen W; Lin W; Chen W
J Invest Surg; 2023 Dec; 36(1):1-10. PubMed ID: 36341742
[TBL] [Abstract][Full Text] [Related]
20. Survival in endometrial cancer in relation to minimally invasive surgery or open surgery - a Swedish Gynecologic Cancer Group (SweGCG) study.
Borgfeldt C; Holmberg E; Marcickiewicz J; Stålberg K; Tholander B; Lundqvist EÅ; Flöter-Rådestad A; Bjurberg M; Dahm-Kähler P; Hellman K; Hjerpe E; Kjölhede P; Rosenberg P; Högberg T
BMC Cancer; 2021 Jun; 21(1):658. PubMed ID: 34078319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
